TickerFacts.

Volitionrx Ltd (VNRX): Operating Cash Flow

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2015-12-31, 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$19.68M
Year ended 2025-12-31
-$19.56M
Trailing 12 months to 2026-06-30
2011-12-31: -$1.65M2012-12-31: -$2.31M2013-12-31: -$3.08M2014-12-31: -$4.14M2015-12-31: -$8.55M2016-12-31: -$8.86M2017-12-31: -$12.19M2018-12-31: -$14.73M2019-12-31: -$12.74M2020-12-31: -$16.46M2021-12-31: -$20.85M2022-12-31: -$15.28M2023-12-31: -$18.06M2024-12-31: -$25.89M2025-12-31: -$19.68M-$19.68M
2011-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$19.68Mn/m2026-03-31, From 2025-01-01
2024-12-31-$25.89Mn/m2026-03-31, From 2024-01-01
2023-12-31-$18.06Mn/m2025-03-31, From 2023-01-01
2022-12-31-$15.28Mn/m2024-03-25, From 2022-01-01
2021-12-31-$20.85Mn/m2023-03-15, From 2021-01-01
2020-12-31-$16.46Mn/m2022-03-30, From 2020-01-01
2019-12-31-$12.74Mn/m2021-03-22, From 2019-01-01
2018-12-31-$14.73Mn/m2020-02-20, From 2018-01-01
2017-12-31-$12.19Mn/m2019-03-13, From 2017-01-01
2016-12-31-$8.86Mn/c2018-03-01, From 2016-01-01
2015-12-31-$8.55Mn/c2017-03-10, From 2015-01-01
2014-12-31-$4.14Mn/m2016-03-11, From 2014-01-01
2013-12-31-$3.08Mn/m2015-03-18, From 2013-01-01
2012-12-31-$2.31Mn/m2014-03-28, From 2012-01-01
2011-12-31-$1.65Mn/a2013-04-01, From 2011-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Volitionrx Ltd (VNRX)2025-12-31-$19.68Mn/m
Celldex Therapeutics, Inc. (CLDX)2025-12-31-$210.94Mn/m
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31-$22.18Mn/m
Biomerica Inc (BMRA)2026-05-31-$3.42Mn/m
Anbio Biotechnology (NNNN)2025-12-31-$6.74Mn/m
Aspira Women's Health Inc. (AWHL)2025-12-31-$7.03Mn/m
Immucell Corp (ICCC)2025-12-31$2.48M+591.6%
Alpha Teknova, Inc. (TKNO)2025-12-31-$8.65Mn/m
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$394.74Mn/m

Compare VNRX, CLDX, IMDX, BMRA side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗